A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone

Authors

Jianqing Lin, George Washington University
Sheel A. Patel
Ashwin R. Sama
Jean H. Hoffman-Censits
Brooke Kennedy
Deborah Kilpatrick
+8 additional authors

Document Type

Journal Article

Publication Date

11-2016

Journal

Oncologist

Volume

21

Issue

11

Inclusive Pages

1296-1297

DOI

10.1634/theoncologist.2016-0297

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Lin, J., Patel, S. A., Sama, A. R., Hoffman-Censits, J. H., Kennedy, B., Kilpatrick, D., & +8 additional authors (2016). A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone. Oncologist, 21 (11). http://dx.doi.org/10.1634/theoncologist.2016-0297

Peer Reviewed

1

Open Access

1